Androgen receptor in hepatocarcinogenesis: Recent developments and perspectives.

作者: YE Tian , XU Xie , Yao Lin , Guang Tan , WU Zhong

DOI: 10.3892/OL.2015.3025

关键词:

摘要: Previous studies have indicated that males are at a higher risk of developing hepatocellular carcinoma (HCC) compared with females. Identifying the factors cause this gender-specific difference in incidence HCC has long been considered important for revealing molecular mechanisms involved hepatocarcinogenesis. Given unprecedented tools now available research, genetic established androgen receptor (AR) may be partly responsible gender disparity HCC. AR dual role, promoting initiation and development, as well suppressing metastasis. The present review provides an overview involvement signaling highlighted studies, examples direct transcriptional target genes novel theories concerning conventional concept, suggesting targeting AR, rather than androgen, provide improved therapeutic approach treatment

参考文章(64)
YE TIAN, HAN WAN, GUANG TAN, Cell cycle-related kinase in carcinogenesis. Oncology Letters. ,vol. 4, pp. 601- 606 ,(2012) , 10.3892/OL.2012.828
J A Simental, M Sar, M V Lane, F S French, E M Wilson, TRANSCRIPTIONAL ACTIVATION AND NUCLEAR TARGETING SIGNALS OF THE HUMAN ANDROGEN RECEPTOR Journal of Biological Chemistry. ,vol. 266, pp. 510- 518 ,(1991) , 10.1016/S0021-9258(18)52466-2
Donald J. Tindall, Haojie Huang, Lucy J. Schmidt, Ofelia L. Zegarra-Moro, Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells. Cancer Research. ,vol. 62, pp. 1008- 1013 ,(2002)
Mausumi Bharadwaj, Gaurav Roy, Koushik Dutta, Mohammad Misbah, Mohammad Husain, Showket Hussain, Tackling hepatitis B virus-associated hepatocellular carcinoma—the future is now Cancer and Metastasis Reviews. ,vol. 32, pp. 229- 268 ,(2013) , 10.1007/S10555-012-9412-6
Yee Chao, Wing-Kai Chan, Yi-Shin Huang, Ho-Chung Teng, Sun-Sang Wang, Wing-Yiu Lui, Jacqueline Whang-Peng, Shou-Dong Lee, Phase II study of flutamide in the treatment of hepatocellular carcinoma. Cancer. ,vol. 77, pp. 635- 639 ,(1996) , 10.1002/(SICI)1097-0142(19960215)77:4<635::AID-CNCR8>3.0.CO;2-F
Junping Ao, Jiao Meng, Lei Zhu, Huizhen Nie, Chenchen Yang, Jinjun Li, Jianren Gu, Qiushi Lin, Weiwen Long, Xiaoqun Dong, Chao Li, Activation of androgen receptor induces ID1 and promotes hepatocellular carcinoma cell migration and invasion Molecular Oncology. ,vol. 6, pp. 507- 515 ,(2012) , 10.1016/J.MOLONC.2012.06.005
M. Barone, M. Margiotta, M.P. Scavo, A. Gentile, D. Francioso, S. Papagni, A. Castellaneta, R. Mallamaci, A. Di Leo, A. Francavilla, Possible involvement of androgen receptor alterations in hepatocarcinogenesis Digestive and Liver Disease. ,vol. 41, pp. 665- 670 ,(2009) , 10.1016/J.DLD.2008.12.099
Y. Tian, C.-f. Kuo, W.-l. Chen, J.-h. J. Ou, Enhancement of Hepatitis B Virus Replication by Androgen and Its Receptor in Mice Journal of Virology. ,vol. 86, pp. 1904- 1910 ,(2012) , 10.1128/JVI.06707-11
Zhaoyu Li, Geetu Tuteja, Jonathan Schug, Klaus H. Kaestner, Foxa1 and Foxa2 Are Essential for Sexual Dimorphism in Liver Cancer Cell. ,vol. 148, pp. 72- 83 ,(2012) , 10.1016/J.CELL.2011.11.026